Category: by subject

“Sufficiently serious” issues in study prompt company to yank drug approval application in China

The maker of a leading over-the-counter antacid has withdrawn its application for approval of the drug in China because a clinical trial of the product in that country was marred by “major protocol deviations.”

Researchers for the company, Reckitt Benckiser, maker of Gaviscon, had published a report on the study in 2015 in the journal Alimentary Pharmacology & Therapeutics. But the journal has now retracted the article, “Randomised clinical trial: The clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China,” at the behest of the drug maker.

According to the notice: Continue reading “Sufficiently serious” issues in study prompt company to yank drug approval application in China

Harvard and the Brigham recommend 31 retractions for cardiac stem cell work

Piero Anversa

Retraction Watch readers may be familiar with the name Piero Anversa. Until several years ago, Anversa, a scientist at Harvard Medical School and the Brigham and Women’s Hospital, was a powerful figure in cardiac stem cell research.

“For ten years, he ran everything,” says Jeffery Molkentin, a researcher at Cincinnati Children’s whose lab was among the first to question the basis of Anversa’s results in a 2014 paper in Nature. Continue reading Harvard and the Brigham recommend 31 retractions for cardiac stem cell work

Four years after readers raise concerns, journal finally retracts climate paper

The wheels of scientific publishing turn slowly … but they do (sometimes) turn.

In January, we reported on the case of a paper on global warming marred by several problems, including allegations of plagiarism and “false claims” by the authors — which readers had raised as early as 2014, with no result. (Find a discussion of those allegations here.)

Now, the journal, Elsevier’s Renewable and Sustainable Energy Reviews (ironic on multiple levels, when you think about it), is retracting the paper.

According to the long-time-in-coming retraction notice: Continue reading Four years after readers raise concerns, journal finally retracts climate paper

What really happened when two mathematicians tried to publish a paper on gender differences? The tale of the emails

Quillette

Retraction Watch readers may be familiar with the story of a paper about gender differences by two mathematicians. Last month, in Weekend Reads, we highlighted an account of that story, which appeared in Quillette.

The piece, by one of the paper’s authors — titled “Academic Activists Send a Published Paper Down the Memory Hole” — touches on issues familiar to those who follow the culture wars, which isn’t all that surprising given the controversial topic, one once discussed by then-Harvard president Larry Summers.

The piece has generated a great deal of conversation, some of it quite heated, and a number of participants in those conversations have suggested that seeing the emails that the author of the Quillette piece says support his account would be useful. That’s what this post is mostly designed to do: Surface those emails. Continue reading What really happened when two mathematicians tried to publish a paper on gender differences? The tale of the emails

Researcher who once tried to sue critics has another dozen papers retracted

Fazlul Sarkar

A cancer researcher who went to court — unsuccessfully — claiming that commenters on PubPeer had cost him a new job has just lost another 12 papers.

The twelve now-retracted papers by Fazlul Sarkar and colleagues — as well as another by Sarkar that is now subject to an editor’s note — all appeared in Cancer Research, which made for a long table of contents in its September 15 issue. Continue reading Researcher who once tried to sue critics has another dozen papers retracted

Japanese university revokes PhD following a retraction

Tokyo Women’s Medical University has stripped a researcher of her PhD, following the retraction of a paper — for data duplication — that was based on her thesis.

The August 30th announcement notes that a degree was revoked on July 20. The announcement does not name the researcher, but refers to degree number 2881, which corresponds to Rika Nakayama’s PhD. The university describes carelessness and errors, but not misconduct.

Here’s a rough Google translation of the announcement: Continue reading Japanese university revokes PhD following a retraction

When it comes to retracting papers by the world’s most prolific scientific fraudsters, journals have room for improvement

Journals have retracted all but 19 of the 313 tainted papers linked to three of the most notorious fraudsters in science, with only stragglers left in the literature. But editors and publishers have been less diligent when it comes to delivering optimal retraction notices for the affected articles.

That’s the verdict of a new analysis in the journal Anaesthesia, which found that 15% of retraction notices for the affected papers fail fully to meet standards from the Committee for Publication Ethics (COPE). Many lacked appropriate language and requisite watermarks stating that the articles had been removed, and some have vanished from the literature.

The article was written by U. M. McHugh, of University Hospital in Galway, Ireland, and Steven Yentis, a consultant anaesthetist at Chelsea & Westminster Hospital in London. Yentis was editor of Anaesthesia during the three scandals and had a first-hand view of two of the investigations. He also is the editor who unleashed anesthetist and self-trained statistician John Carlisle on the Fujii papers to see how likely the Japanese researcher’s data were to be valid (answer: not very likely). Continue reading When it comes to retracting papers by the world’s most prolific scientific fraudsters, journals have room for improvement

Cancer journals retract 10 papers, flag 8 more, and apologize for the delay

Bharat Aggarwal

Five journals published by a prominent cancer research society have retracted a total of 10 papers — most of them by a former researcher at the MD Anderson Cancer Center in Houston.

Nine of the 10 retractions share that researcher, Bharat Aggarwal, as an author. Aggarwal — who more than five years ago threatened to sue us for reporting on an investigation into his work — is now up to 28 retractions, and has left his post at MD Anderson. The AACR is also appending an editor’s note to eight of his other papers — but it has not explained the reason for what it acknowledges is a lag in moving on these articles.

“Unfortunately, we have been delayed in correcting the published record, and for this we apologize,” writes the publisher of The American Association for Cancer Research (AACR), Christine Rullo, in a note in this month’s issue of Cancer Research. Rullo doesn’t say how long the journals took to handle the retractions. Continue reading Cancer journals retract 10 papers, flag 8 more, and apologize for the delay

Prominent video game-violence researcher loses another paper to retraction

Brad Bushman

If you read this space, you probably know the name Brad Bushman. He studies the effects of violent video games on the people who play them. He also has just retracted his third paper, and significantly corrected another.

Although Bushman remains a prominent voice in a highly contentious field — prompting numerous media to consult him after school shootings or other violent acts — he’s retracted two papers, one following an investigation at his institution, the Ohio State University (OSU), which prompted OSU to strip his co-author of her PhD. (There’s a lot more to tell about that story, including the backlash outside critics faced for taking their concerns about the paper public. To read more, check out our in-depth piece in Motherboard.)

Bushman’s third retraction came this month; he nearly had a fourth as well, but attorneys for the publisher decided that a massive correction (to a paper which previously had been flagged with an expression of concern) would be more appropriate.

The retraction notice from Current Opinion in Psychology states the paper showed too much similarity to a 2016 paper in the same journal by Bushman and Arlin James Benjamin, based at the University of Arkansas-Fort Smith. It notes that although Bushman was the guest editor of the issue of the journal:

Continue reading Prominent video game-violence researcher loses another paper to retraction

UPDATED: Elsevier retracts a paper on solar cells that appears to plagiarize a Nature journal. But the reason is…odd.

The similarities between recent papers in two different journals about energy were striking — so striking that a number of people have taken to Twitter and Facebook to let the world know about them.

[1415 UTC, August 29, 2018: See update at the end of this post.]

One paper, “Systematic investigation of the impact of operation conditions on the degradation behaviour of perovskite solar cells,” was authored by a group of researchers in Lausanne, Switzerland and appeared on January 1, 2018 in Nature Energy. Its abstract reads: Continue reading UPDATED: Elsevier retracts a paper on solar cells that appears to plagiarize a Nature journal. But the reason is…odd.